Genmab
Differentiated human antibody therapeutics for the treatment of cancer
2981 employees · est. 1999 · Denmark
Klus Pharma Inc.
Discovery and development of novel and safer antibody-based therapeutics.
11 employees · est. 2014 · Princeton, United States
Genmab is the older company (1999 vs 2014); Genmab is the larger of the two.
Side-by-Side Comparison
| Metric | Genmab | Klus Pharma Inc. |
|---|---|---|
| Founded | ||
| Founded | 1999 older | 2014 |
| Headquarters | ||
| Headquarters | Denmark | Princeton, United States |
| Employees | ||
| Employees | 2981 larger | 11 |
| Industry | ||
| Industry | Biotechnology, Pharmaceutical | Manufacturing, Pharmaceutical, Marketing |
| Funding Stage | ||
| Funding Stage | IPO | Not tracked yet |
| Total Funding | ||
| Total Funding | $2.28B | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 6 | Not tracked yet |
| Services | ||
| Services | Development of Antibody Therapeutics, Pipeline of Medicines, Biotech Research | Not tracked yet |
| Target Customers | ||
| Target Customers | Healthcare Professionals, Patients & Care Partners, Investors, Corporate Partners | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Antibody Therapeutics, Cancer Treatment, Bispecific Antibodies, Antibody-Drug Conjugates, Immune-Modulating Antibodies, Clinical Pipeline, Innovative Medicines, Antibody Innovation, Late-stage Clinical Trials, Biopharmaceuticals, Healthcare Innovation, Unmet Medical Needs, Drug Development | Biologics Drug Discovery And Development, Antibody Discovery, Antibody-drug Conjugates (ADC), Clinical Development, Bispecific Antibodies, Multispecific Antibodies, Immuno-oncology |
| Website | ||
| Website | genmab.com | kluspharma.com |
About Genmab
Genmab, founded in 1999, is a pioneering international biotechnology company headquartered in Denmark. Renowned for its expertise in antibody innovation, Genmab focuses on developing differentiated human antibody therapeutics aimed at treating cancer and other serious diseases. Through its innovativ...
About Klus Pharma Inc.
Klus Pharma Inc. is a subsidiary of Kelun Group and affiliated with Kelun-Biotech, focusing on the discovery and development of advanced therapeutic biotechnologies. Established in 2014, the company's primary aim is to address the unmet needs of patients suffering from various severe disorders such...
We will tell you when either one moves
BounceWatch watches Genmab and Klus Pharma Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Genmab and Klus Pharma Inc. — by email.
Frequently Asked Questions
Compare Genmab with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Genmab on 25 Jun 2026, and Klus Pharma Inc. on 14 Nov 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.